| Name | basic helix-loop-helix ARNT like 2 |
| Description | This gene encodes a basic helix-loop-helix transcription factor belonging to the PAS (PER, ARNT, SIM) superfamily. The PAS proteins play important roles in adaptation to low atmospheric and cellular oxygen levels, exposure to certain environmental pollutants, and diurnal oscillations in light and temperature. This protein forms a transcriptionally active heterodimer with the circadian CLOCK protein, the structurally related MOP4, and hypoxia-inducible factors, such as HIF1alpha. Consistent with its role as a biologically relevant partner of circadian and hypoxia factors, this protein is coexpressed in regions of the brain such as the thalamus, hypothalamus, and amygdala. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Oct 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nBMAL2, a member of the basic helix–loop–helix PER–ARNT–SIM family, functions as a core transcriptional regulator of the circadian clock by heterodimerizing with CLOCK. Alternative splicing of BMAL2 generates multiple isoforms with a wide range of transcriptional activities, thereby providing tissues with a flexible “rheostat” to fine‐tune the amplitudes of both central and peripheral circadian oscillators. Moreover, BMAL2 displays distinct transcriptional activation properties compared with its paralog BMAL1, including differential modulation by negative regulators such as PER2 and CRY2 that depend on the specific E-box elements in target promoters."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAlterations in BMAL2 expression and genetic variation have been implicated in neurological and metabolic disorders. For example, decreased BMAL2 expression in total leukocytes has been observed in patients with Parkinson’s disease, suggesting a disturbance of the molecular clock in this neurodegenerative condition. Furthermore, polymorphisms in BMAL2 are associated with Alzheimer’s disease susceptibility—particularly among APOE ε4 non-carriers—and BMAL2 has been evaluated as a candidate gene affecting glucose homeostasis and type 2 diabetes risk."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "3", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its canonical role in circadian regulation, BMAL2 (also known as ARNTL2) contributes to immune and oncogenic processes. In the context of inflammatory responses, BMAL2 is induced by extracellular cold-inducible RNA-binding protein and promotes macrophage endotoxin tolerance via TREM-1 signaling. In addition, increased BMAL2/ARNTL2 expression has been linked to the progression of several cancers—including bladder cancer, acute myeloid leukemia, and nasopharyngeal carcinoma—by enhancing cell proliferation, migration, invasion, and metastasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "John A Schoenhard, Mesut Eren, Carl H Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alternative splicing yields novel BMAL2 variants: tissue distribution and functional characterization."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00541.2001"}], "href": "https://doi.org/10.1152/ajpcell.00541.2001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12055078"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12055078"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Momoko Sasaki, Hikari Yoshitane, Ngoc-Hien Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Preferential inhibition of BMAL2-CLOCK activity by PER2 reemphasizes its negative role and a positive role of BMAL2 in the circadian transcription."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M109.040758"}], "href": "https://doi.org/10.1074/jbc.M109.040758"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19605937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19605937"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hui Ding, Shu Liu, Yanpeng Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased expression of Bmal2 in patients with Parkinson's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurosci Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neulet.2011.05.058"}], "href": "https://doi.org/10.1016/j.neulet.2011.05.058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21658431"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21658431"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Liu Qing-Xiu, Huang Chang-Quan, Chen Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The polymorphism of ARNTL2 (BMAL2) gene rs2306074 C>T is associated with susceptibility of Alzheimer disease in Chinese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurol Sci (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10072-014-1824-3"}], "href": "https://doi.org/10.1007/s10072-014-1824-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24847962"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24847962"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Miwa Yamaguchi, Hirokazu Uemura, Kokichi Arisawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: A cross-sectional analysis of the Japan Multi-institutional Collaborative Cohort Study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes Res Clin Pract (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.diabres.2015.10.009"}], "href": "https://doi.org/10.1016/j.diabres.2015.10.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26497775"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26497775"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Mian Zhou, Monowar Aziz, Jingsong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BMAL2 promotes eCIRP-induced macrophage endotoxin tolerance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Front Immunol (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3389/fimmu.2024.1426682"}], "href": "https://doi.org/10.3389/fimmu.2024.1426682"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38938563"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38938563"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jiahao Wang, Junwei Ren, Xiang Tu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2024.122974"}], "href": "https://doi.org/10.1016/j.lfs.2024.122974"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "39147318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/39147318"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Wei-Jing Jia, Jiao Mu, Wen-Jing Cui "}, {"type": "b", "children": [{"type": "t", "text": "[Effects of BMAL2 on Aerobic Glycolysis and Cell Proliferation in Acute Myeloid Leukemia Cells]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhongguo Shi Yan Xue Ye Xue Za Zhi (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.19746/j.cnki.issn.1009-2137.2024.02.012"}], "href": "https://doi.org/10.19746/j.cnki.issn.1009-2137.2024.02.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38660843"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38660843"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Wenqing Zou, Yiming Lei, Cong Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The circadian gene ARNTL2 promotes nasopharyngeal carcinoma invasiveness and metastasis through suppressing AMOTL2-LATS-YAP pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-024-06860-x"}], "href": "https://doi.org/10.1038/s41419-024-06860-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38956029"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38956029"}]}]}]}
|
| NCBI Gene ID | 56938 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
BMAL2 has 2,844 functional associations with biological entities spanning 5 categories (chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 28 datasets.
Click the + buttons to view associations for BMAL2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of BMAL2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of BMAL2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with BMAL2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of BMAL2 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing BMAL2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 | cellular components containing BMAL2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with BMAL2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving BMAL2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing BMAL2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by BMAL2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of BMAL2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with BMAL2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of BMAL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of BMAL2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of BMAL2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of BMAL2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| Reactome Pathways 2024 | pathways involving BMAL2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of BMAL2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of BMAL2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of BMAL2 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of BMAL2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of BMAL2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of BMAL2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of BMAL2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of BMAL2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of BMAL2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with BMAL2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2024 | pathways involving BMAL2 protein from the WikiPathways Pathways 2024 dataset. | |